Independent market intelligence
Understand the markets. Follow what matters.
Clear coverage of stocks, capital markets, and the economic forces moving them—grounded in linked primary sources.
Research the numbers behind the headline
Build a cash-flow valuation with sensitivity analysis, map who receives equity-offering proceeds, or examine reported quarterly fundamentals. Inputs stay in your browser.
Explore by purpose
Stock Market
Company moves, earnings, sectors, and market signals explained with context.
Capital Markets
IPOs, follow-ons, debt, deal activity, and the mechanics behind financing markets.
Market Education
Practical guides that explain terms, tools, risks, and how to read market data.
Latest analysis
Iambic Therapeutics Files Form S-1 for Nasdaq IPO Under IAM
Iambic Therapeutics filed a Form S-1 with the SEC to list on Nasdaq under IAM, backed by Nvidia and Coatue, with $207.9M in cash and clinical HER2 data.
Group 1 Automotive Inks Pact With Conifer, Expands Board
Group 1 Automotive entered a stockholder agreement with 12.7% owner Conifer Management, expanding its board to 11 and capping Conifer at 19% ownership.
Tax-Equivalent Yield: How to Compare Munis and Treasuries
Learn how to calculate tax-equivalent yield (TEY) to compare municipal bonds, U.S. Treasuries, and corporate debt on a true after-tax basis.
Priority Technology Inks $1.6B Buyout With CEO and Searchlight
Priority Technology will be taken private by CEO Thomas Priore and Searchlight Capital in a $1.6B cash deal at $8.05 per share, delisting PRTH from Nasdaq.
How we work
We distinguish reported facts from analysis, link readers to the underlying evidence, and publish visible corrections when material errors are confirmed.
Read the Editorial Policy · Request a correction · About ECMSource